NRXP Stock Analysis: Buy, Sell, or Hold?
NRXP - NRX Pharmaceuticals, Inc. Common Stock
$3.76
-0.14 (-3.59%)
▼
5d:
-7.84%
30d:
+22.88%
90d:
+112.43%
HOLD
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Get Alerted When NRXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NRXP shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.29
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.52
16.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NRXP is currently trading at $3.76, which is considered fair relative to its 30-day fair value range of $3.40 to $4.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.5) compared to its historical average (10.4). Remarkably, the market is currently pricing in an annual earnings decline of 10.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $3.45, while resistance sits at $5.05. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.00 (+1017.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NRXP is in a strong uptrend. Immediate support is located at $3.45, while resistance sits at $5.05. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.00 (+1017.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.40 -
$4.37
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
Protect Your Profits
Holding NRXP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BULLISH: Trading 1017.0% below Wall St target ($42.00)
- CAUTION: Recommendation downgraded due to -7.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.40 -
$4.37
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.45
Resistance Level
$5.06
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.52
Wall Street Target
$42.00
(+1017.0%)
Valuation Discount vs History
-10.2% cheaper
PE vs Historical
7.5 vs 10.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.2%
(market-implied from PE analysis)
1-Year Target
$3.38
(-10%)
2-Year Target
$3.05
(-19%)
3-Year Target
$2.74
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→10)
$3.79
(+1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 10.4
Stabilization Target:
$5.20
(+38.3%)
PE Expansion Potential:
+38.3%
Share & Embed Analysis
Last updated: June 23, 2026 7:54 PM ET
Data refreshes hourly during market hours. Next update: 8:54 PM
Data refreshes hourly during market hours. Next update: 8:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
Advanced NRXP Option Strategies
Professional options setups generated by AI based on today's NRXP price and gamma walls.
